Article 1
Annex II to Decision 2008/911/EC is amended in accordance with the Annex to this Decision.
Commission Implementing Decision (EU) 2016/1658 of 13 September 2016 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2016) 5747) (Text with EEA relevance)
Commission Implementing Decision (EU) 2016/1658 of 13 September 2016 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2016) 5747) (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Article 2
This Decision is addressed to the Member States.
Supplementary provisions
ANNEXSupplementary provisions
ANNEX In Annex II to Decision 2008/911/EC, the entry Eleutherococcus Senticosus (Rupr. et Maxim) Maxim., Radix is amended as follows: (1) The section ‘Common name in all EU official languages of herbal substance’ is amended as follows: (a) After ‘FR (français): racine d'éleuthérocoque (racine de ginseng sibérien)’ the following is inserted: ‘HR (hrvatska): Korijen sibirskog ginsenga’ (b) ‘Všehojovcový koreň’ related to SK (slovenčina) is replaced by ‘Koreň eleuterokoka’; (2) The section ‘Herbal preparation(s)’ is amended as follows: (a) ‘Comminuted herbal substance for preparation of herbal tea’ is replaced by ‘Comminuted herbal substance’; (b) ‘Liquid extract (1:1, ethanol 30-40 % v/v)’ is replaced by ‘Liquid extract (DER 1:1, extraction solvent ethanol 30-40 % v/v)’; (c) ‘Dry extract (13-25: 1, ethanol 28-40 % v/v)’ is replaced by ‘Dry extract (DER 13-25:1, extraction solvent ethanol 28-40 % v/v)’; (d) ‘Dry aqueous extract (15-17:1)’ is replaced by ‘Dry aqueous extract (DER 15-17:1)’; (e) ‘Tincture (1:5, ethanol 40 % v/v)’ is replaced by ‘Tincture (ratio of herbal substance to extraction solvent 1:5, extraction solvent ethanol 40 % v/v)’; (3) In the section ‘European Pharmacopoeia monograph reference’‘6.0’ is replaced by ‘7.0’; (4) In the section ‘Type of tradition’‘Chinese, European.’ is replaced by ‘European, Chinese.’; (5) In the section ‘Specified strength’‘Not applicable.’ is replaced by ‘Please see “Specified posology”.’; (6) The section ‘Specified posology’ is amended as follows: (a) ‘over 12 years of age’ is deleted; (b) ‘Daily dose.’ is replaced by ‘Average daily dose.’; (c) ‘The use is not recommended in children under 12 years of age’ is replaced by ‘The use in children under 12 years of age is not recommended’; (7) The section ‘Any other information necessary for the safe use’ is amended as follows: (a) ‘Contra-indications’ is replaced by ‘Contraindication’; (b) The words ‘Arterial hypertension.’ are deleted; (c) The sentence ‘The use in children under 12 years of age is not recommended because sufficient experience is not available’ are replaced by ‘The use in children under 12 years of age is not recommended due to lack of adequate data’; (d) After ‘If the symptoms worsen during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.’ the sentence ‘For tinctures and extracts containing ethanol the appropriate labelling for ethanol, taken from the Guideline on excipients in the label and package leaflet of medicinal products for human use, must be included.’ is inserted; (e) The title of subsection ‘Pregnancy and lactation’ is replaced by ‘Fertility, pregnancy and lactation’; After the sentence ‘In the absence of sufficient data, the use during pregnancy and lactation is not recommended.’ ‘No fertility data available.’ is inserted; (f) In subsection ‘Undesirable effects’ after ‘The frequency is not known.’ The sentence ‘If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted.’ is inserted; (g) After subsection ‘Overdose’ the following subsections are inserted: ‘Pharmaceutical particulars (if necessary) Not applicable. Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product) Not applicable.’
Other acts of the same type
Commission Implementing Decision (EU) 2025/503 of 18 March 2025 laying down rules for the application of Regulation (EU) 2024/1351 of the European Parliament and of the Council, as regards the template to be used by Member States to ensure that their national asylum and migration management strategies are comparable on specific core elementsCouncil Implementing Decision (EU) 2025/539 of 18 March 2025 authorising Estonia to apply a special measure derogating from Article 26(1), point (a), and Articles 168 and 168a of Directive 2006/112/EC on the common system of value added taxCouncil Decision (EU) 2025/542 of 18 March 2025 establishing the position to be taken on behalf of the European Union regarding the decision of the Participants to the Sector Understanding on Export Credits for Civil Aircraft contained in Annex III to the Arrangement on Officially Supported Export Credits on amendments to that Sector UnderstandingCommission Implementing Decision (EU) 2025/485 of 17 March 2025 concerning the extension of the action taken by the Health and Safety Executive of the United Kingdom permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 1565)Commission Implementing Decision (EU) 2025/489 of 17 March 2025 concerning the extension of the action taken by Malta Competition and Consumer Affairs Authority permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 1560)Commission Implementing Decision (EU) 2025/495 of 17 March 2025 concerning the extension of the action taken by the Belgian Federal Public Service Health, Food Chain Safety and Environment permitting the making available on the market and use of the biocidal product Interox SG 35 Plus in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCouncil Implementing Decision (CFSP) 2025/510 of 17 March 2025 implementing Decision 2010/788/CFSP concerning restrictive measures in view of the situation in the Democratic Republic of the CongoCouncil Decision (CFSP) 2025/514 of 17 March 2025 amending Decision (CFSP) 2016/1693 concerning restrictive measures against ISIL (Da’esh) and Al-Qaeda and persons, groups, undertakings and entities associated with themCouncil Decision (CFSP) 2025/529 of 17 March 2025 on Union support for the United Nations Institute for Disarmament Research project ‘Science and Technology Watchtower: Monitoring Innovation for Disarmament’Council Implementing Decision (EU) 2025/657 of 17 March 2025 establishing the satisfactory fulfilment of the conditions for the payment of the third instalment of the non-repayable financial support and of the loan support under the Ukraine Plan of the Ukraine FacilityCouncil Decision (EU) 2025/702 of 17 March 2025 authorising the European Commission to take part, on behalf of the Union, in the negotiations for an international instrument setting up an International Claims Commission for UkraineCommission Implementing Decision (EU) 2025/483 of 14 March 2025 not granting a Union authorisation for the biocidal product family INTERKOKASK in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2025) 1556)
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview